Physician profile
Amanda Piper
NPI 1154976314
$662.54
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.68 · 2022: $139 · 2023: $185 · 2024: $158 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $162.66 | 2022-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $90.95 | 2023-2025 | |
| Glaxosmithkline, LLC. | $74.51 | 2021-2025 | Pediarix, Penmenvy, Rotarix |
| Ironshore Pharmaceuticals INC. | $65.40 | 2022-2024 | |
| Cranial Technologies, INC | $45.38 | 2022-2023 | Doc Band |
| Collegium Pharmaceutical, INC. | $43.18 | 2025 | Jornay Pm |
| Corium, LLC | $42.31 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $40.07 | 2022-2025 | Qelbree |
| Alk-Abello, INC | $39.99 | 2024 | Odactra, Grastek, Ragwitek |
| Verrica Pharmaceuticals INC. | $30.16 | 2023 | Ycanth |
| Tms Neurohealth Centers INC. | $15.47 | 2025 | Tms Neurohealth Centers INC. |
| Abbvie INC. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Piper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.